News NICE to reassess Pfizer blood cancer drug Company successfully appealed against rejection last summer
News Pfizer facing NICE showdown over leukaemia drug Pfizer locks horns with NICE following EU approval.
News NICE backs Amgen's Blincyto in rare leukaemia Drug will also be available to children via Cancer Drugs Fund.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
